Skip to contentS
SeaStar Medical Holding Corp
S
ICUCWSeaStar Medical Holding Corp Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$420.00K$420.00Kderived+526.9% vs Q4 2024 Net Income-$2.90M-$2.90MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SeaStar Medical Holding Corp · CIK 1831868 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$408,000+509.0% Operating Incomederived-$3,018,000N/M Operating Cash Flowderived-$4,094,000N/M Margins · derivedGross margin97.1%−2.9 pt vs Q4 2024
Operating margin-718.6%+6396.4 pt vs Q4 2024
Net margin-691.4%+5904.1 pt vs Q4 2024
ended Dec 31, 2025 · filed Mar 25, 2026 · 84 d after period end